K. Gary Barnette
About K. Gary Barnette
Title and Current Role
K. Gary Barnette currently holds the position of Chief Scientific Officer. In this role, he leverages his extensive experience in pharmaceutical sciences, clinical pharmacology, and pharmacokinetics to lead scientific endeavors.
Educational Background
K. Gary Barnette earned a Ph.D. in Basic Pharmaceutical Sciences, specializing in Clinical Pharmacology and Pharmacokinetics, from West Virginia University, School of Pharmacy. His advanced education has equipped him with profound expertise in drug development and regulatory affairs.
Experience at Camargo Pharmaceutical Services
K. Gary Barnette served as Sr. Vice President of Scientific and Regulatory Affairs at Camargo Pharmaceutical Services, LLC for 6 years. In this role, he oversaw scientific and regulatory drug development strategies across all therapeutic areas, contributing significantly to the company's success.
Tenure at GTx, Inc.
From 2000 to 2012, K. Gary Barnette worked at GTx, Inc. in various roles, most notably as Vice President, Clinical Development Strategy. He managed responsibilities across regulatory, clinical, clinical pharmacology, and medical affairs departments, focusing on urology and cancer supportive care.
Role at U.S. FDA
K. Gary Barnette held the position of Clinical Pharmacology and Biopharmaceutics Reviewer at the U.S. FDA. During his tenure, he received numerous awards for his contributions in reviewing, mentoring, and participating in various FDA guidance development groups and initiative task forces.